Clinical Trials Browser

Phase 2 × OTHER × Virus Diseases × Clear all

NCT02532452 2025-12-16

Third Party Viral Specific T-cells (VSTs)

Phase 2 Recruiting

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT01136395 2019-10-08

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Phase 2 Completed

Virus Diseases, Epstein-Barr Virus Infections